Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients.

Norton N, Youssef B, Hillman DW, Nassar A, Geiger XJ, Necela BM, Liu H, Ruddy KJ, Polley MC, Ingle JN, Couch FJ, Perez EA, Liu MC, Carter JM, Leon-Ferre RA, Boughey JC, Somers EB, Kalari KR, Visscher DW, Goetz MP, Knutson KL.

NPJ Breast Cancer. 2020 Feb 4;6:4. doi: 10.1038/s41523-020-0147-1. eCollection 2020.

2.

Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease.

Adhikary S, Hoskin TL, Stallings-Mann ML, Arshad M, Frost MH, Winham SJ, Peña A, Lee DJ, Murphy LM, Rakoff M, Denison LA, Knutson KL, Radisky DC, Visscher DW, Degnim AC.

Breast Cancer Res Treat. 2020 Feb;180(1):55-61. doi: 10.1007/s10549-019-05493-5. Epub 2020 Jan 13.

PMID:
31933142
3.

Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer.

Multinu F, Chen J, Madison JD, Torres M, Casarin J, Visscher D, Shridhar V, Bakkum-Gamez J, Sherman M, Wentzensen N, Mariani A, Walther-Antonio M.

Gynecol Oncol. 2020 Jan 2. pii: S0090-8258(19)31844-X. doi: 10.1016/j.ygyno.2019.12.023. [Epub ahead of print]

4.

Pathology of breast cancer in the last half century.

Solanki M, Visscher D.

Hum Pathol. 2020 Jan;95:137-148. doi: 10.1016/j.humpath.2019.09.007. Epub 2019 Nov 1.

PMID:
31682887
5.

Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall.

Moyer AM, Yu J, Sinnwell JP, Dockter TJ, Suman VJ, Weinshilboum RM, Boughey JC, Goetz MP, Visscher DW, Wang L.

Oncotarget. 2019 Jun 11;10(39):3924-3930. doi: 10.18632/oncotarget.27001. eCollection 2019 Jun 11.

6.

Genes associated with bowel metastases in ovarian cancer.

Mariani A, Wang C, Oberg AL, Riska SM, Torres M, Kumka J, Multinu F, Sagar G, Roy D, Jung DB, Zhang Q, Grassi T, Visscher DW, Patel VP, Jin L, Staub JK, Cliby WA, Weroha SJ, Kalli KR, Hartmann LC, Kaufmann SH, Goode EL, Shridhar V.

Gynecol Oncol. 2019 Sep;154(3):495-504. doi: 10.1016/j.ygyno.2019.06.010. Epub 2019 Jun 14.

7.

EventFinder: a program for screening remotely captured images.

Janzen M, Ritter A, Walker PD, Visscher DR.

Environ Monit Assess. 2019 May 31;191(6):406. doi: 10.1007/s10661-019-7518-9.

PMID:
31152251
8.

Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy.

Al-Hilli Z, Choong G, Keeney MG, Visscher DW, Ingle JN, Goetz MP, Jakub JW.

Breast Cancer Res Treat. 2019 Aug;176(3):709-716. doi: 10.1007/s10549-019-05264-2. Epub 2019 May 22.

PMID:
31119569
9.

Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation.

Lee HE, Arshad M, Brahmbhatt RD, Hoskin TL, Winham SJ, Frost MH, Radisky DC, Denison LA, Degnim AC, Visscher DW.

Mod Pathol. 2019 Sep;32(9):1263-1270. doi: 10.1038/s41379-019-0217-9. Epub 2019 Apr 17.

PMID:
30996252
10.

Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.

Shieh Y, Scott CG, Jensen MR, Norman AD, Bertrand KA, Pankratz VS, Brandt KR, Visscher DW, Shepherd JA, Tamimi RM, Vachon CM, Kerlikowske K.

Breast Cancer Res. 2019 Apr 3;21(1):48. doi: 10.1186/s13058-019-1129-9.

11.

Skin bioprinting: the future of burn wound reconstruction?

Varkey M, Visscher DO, van Zuijlen PPM, Atala A, Yoo JJ.

Burns Trauma. 2019 Feb 12;7:4. doi: 10.1186/s41038-019-0142-7. eCollection 2019. Review.

12.

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.

Hurley RM, Wahner Hendrickson AE, Visscher DW, Ansell P, Harrell MI, Wagner JM, Negron V, Goergen KM, Maurer MJ, Oberg AL, Meng XW, Flatten KS, De Jonge MJA, Van Herpen CD, Gietema JA, Koornstra RHT, Jager A, den Hollander MW, Dudley M, Shepherd SP, Swisher EM, Kaufmann SH.

Gynecol Oncol. 2019 Apr;153(1):127-134. doi: 10.1016/j.ygyno.2019.01.015. Epub 2019 Jan 25.

PMID:
30686551
13.

WAKMAR2, a Long Noncoding RNA Downregulated in Human Chronic Wounds, Modulates Keratinocyte Motility and Production of Inflammatory Chemokines.

Herter EK, Li D, Toma MA, Vij M, Li X, Visscher D, Wang A, Chu T, Sommar P, Blomqvist L, Berglund D, Ståhle M, Wikstrom JD, Xu Landén N.

J Invest Dermatol. 2019 Jun;139(6):1373-1384. doi: 10.1016/j.jid.2018.11.033. Epub 2018 Dec 27.

14.

Enhanced osteogenic activity by MC3T3-E1 pre-osteoblasts on chemically surface-modified poly(ε-caprolactone) 3D-printed scaffolds compared to RGD immobilized scaffolds.

Zamani Y, Mohammadi J, Amoabediny G, Visscher DO, Helder MN, Zandieh-Doulabi B, Klein-Nulend J.

Biomed Mater. 2018 Nov 13;14(1):015008. doi: 10.1088/1748-605X/aaeb82.

PMID:
30421722
15.

Design and fabrication of a hybrid alginate hydrogel/poly(ε-caprolactone) mold for auricular cartilage reconstruction.

Visscher DO, Gleadall A, Buskermolen JK, Burla F, Segal J, Koenderink GH, Helder MN, van Zuijlen PPM.

J Biomed Mater Res B Appl Biomater. 2019 Jul;107(5):1711-1721. doi: 10.1002/jbm.b.34264. Epub 2018 Nov 1.

16.

Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

Shaik AN, Ruterbusch JJ, Abdulfatah E, Shrestha R, Daaboul MHDF, Pardeshi V, Visscher DW, Bandyopadhyay S, Ali-Fehmi R, Cote ML.

Breast Cancer Res. 2018 Aug 9;20(1):91. doi: 10.1186/s13058-018-1027-6.

17.

Cellular fibroepithelial lesions of the breast: A long term follow up study.

Yasir S, Nassar A, Jimenez RE, Jenkins SM, Hartmann LC, Degnim AC, Frost M, Visscher DW.

Ann Diagn Pathol. 2018 Aug;35:85-91. doi: 10.1016/j.anndiagpath.2018.01.005. Epub 2018 Jan 10.

PMID:
30029048
18.

Review of additive manufactured tissue engineering scaffolds: relationship between geometry and performance.

Gleadall A, Visscher D, Yang J, Thomas D, Segal J.

Burns Trauma. 2018 Jul 3;6:19. doi: 10.1186/s41038-018-0121-4. eCollection 2018. Review.

19.

Functional connectivity in ruminants: A generalized state-dependent modelling approach.

Visscher DR, Merrill EH.

PLoS One. 2018 Jun 26;13(6):e0199671. doi: 10.1371/journal.pone.0199671. eCollection 2018.

20.

Evaluation of 2 breast cancer risk models in a benign breast disease cohort.

Frank RD, Winham SJ, Vierkant RA, Frost MH, Radisky DC, Ghosh K, Brandt KR, Sherman ME, Visscher DW, Hartmann LC, Degnim AC, Vachon CM.

Cancer. 2018 Aug;124(16):3319-3328. doi: 10.1002/cncr.31528. Epub 2018 Jun 22.

21.

3D printing of patient-specific neck splints for the treatment of post-burn neck contractures.

Visscher DO, Te Slaa S, Jaspers ME, van de Hulsbeek M, Borst J, Wolff J, Forouzanfar T, van Zuijlen PP.

Burns Trauma. 2018 Jun 8;6:15. doi: 10.1186/s41038-018-0116-1. eCollection 2018. No abstract available.

22.

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.

Yu J, Qin B, Moyer AM, Nowsheen S, Liu T, Qin S, Zhuang Y, Liu D, Lu SW, Kalari KR, Visscher DW, Copland JA, McLaughlin SA, Moreno-Aspitia A, Northfelt DW, Gray RJ, Lou Z, Suman VJ, Weinshilboum R, Boughey JC, Goetz MP, Wang L.

J Clin Invest. 2018 Jun 1;128(6):2376-2388. doi: 10.1172/JCI97924. Epub 2018 Apr 30.

23.

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.

Degnim AC, Winham SJ, Frank RD, Pankratz VS, Dupont WD, Vierkant RA, Frost MH, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Carter JM, Denison LA, Broderick B, Hartmann LC, Visscher DW, Radisky DC.

J Clin Oncol. 2018 Jun 20;36(18):1840-1846. doi: 10.1200/JCO.2017.75.9480. Epub 2018 Apr 20.

24.

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients.

Kalli KR, Block MS, Kasi PM, Erskine CL, Hobday TJ, Dietz A, Padley D, Gustafson MP, Shreeder B, Puglisi-Knutson D, Visscher DW, Mangskau TK, Wilson G, Knutson KL.

Clin Cancer Res. 2018 Jul 1;24(13):3014-3025. doi: 10.1158/1078-0432.CCR-17-2499. Epub 2018 Mar 15.

25.

Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics.

Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ, Shepherd JA, Fan B, Wu FF, Ma L, Collins LC, Cummings SR, Kerlikowske K, Vachon CM.

Breast Cancer Res Treat. 2018 Jul;170(1):129-141. doi: 10.1007/s10549-018-4735-9. Epub 2018 Mar 3.

26.

Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies.

Shen J, Hu Y, Putt KS, Singhal S, Han H, Visscher DW, Murphy LM, Low PS.

Oncotarget. 2017 Dec 15;9(4):4485-4495. doi: 10.18632/oncotarget.23321. eCollection 2018 Jan 12.

27.

Topically Applied Ceramides Interact with the Stratum Corneum Lipid Matrix in Compromised Ex Vivo Skin.

Berkers T, Visscher D, Gooris GS, Bouwstra JA.

Pharm Res. 2018 Feb 6;35(3):48. doi: 10.1007/s11095-017-2288-y.

28.

Association between mammographic breast density and histologic features of benign breast disease.

Ghosh K, Vierkant RA, Frank RD, Winham S, Visscher DW, Pankratz VS, Scott CG, Brandt K, Sherman ME, Radisky DC, Frost MH, Hartmann LC, Degnim AC, Vachon CM.

Breast Cancer Res. 2017 Dec 19;19(1):134. doi: 10.1186/s13058-017-0922-6.

29.

Degree of Skin Barrier Disruption Affects Lipid Organization in Regenerated Stratum Corneum.

Berkers T, Visscher D, Gooris GS, Bouwstra JA.

Acta Derm Venereol. 2018 Apr 16;98(4):421-427. doi: 10.2340/00015555-2865.

30.

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.

Yu J, Qin B, Moyer AM, Sinnwell JP, Thompson KJ, Copland JA 3rd, Marlow LA, Miller JL, Yin P, Gao B, Minter-Dykhouse K, Tang X, McLaughlin SA, Moreno-Aspitia A, Schweitzer A, Lu Y, Hubbard J, Northfelt DW, Gray RJ, Hunt K, Conners AL, Suman VJ, Kalari KR, Ingle JN, Lou Z, Visscher DW, Weinshilboum R, Boughey JC, Goetz MP, Wang L.

Breast Cancer Res. 2017 Dec 6;19(1):130. doi: 10.1186/s13058-017-0920-8.

31.

Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease.

Carter JM, Hoskin TL, Pena MA, Brahmbhatt R, Winham SJ, Frost MH, Stallings-Mann M, Radisky DC, Knutson KL, Visscher DW, Degnim AC.

Cancer Prev Res (Phila). 2018 Feb;11(2):113-119. doi: 10.1158/1940-6207.CAPR-17-0245. Epub 2017 Nov 22.

32.

CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.

Kerekes D, Visscher DW, Hoskin TL, Radisky DC, Brahmbhatt RD, Pena A, Frost MH, Arshad M, Stallings-Mann M, Winham SJ, Murphy L, Denison L, Carter JM, Knutson KL, Degnim AC.

Breast Cancer Res Treat. 2018 Feb;167(3):649-658. doi: 10.1007/s10549-017-4558-0. Epub 2017 Nov 1.

33.

Semi-automated camera trap image processing for the detection of ungulate fence crossing events.

Janzen M, Visser K, Visscher D, MacLeod I, Vujnovic D, Vujnovic K.

Environ Monit Assess. 2017 Sep 27;189(10):527. doi: 10.1007/s10661-017-6206-x.

PMID:
28956203
34.

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.

Leon-Ferre RA, Polley MY, Liu H, Gilbert JA, Cafourek V, Hillman DW, Elkhanany A, Akinhanmi M, Lilyquist J, Thomas A, Negron V, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Visscher DW, Goetz MP.

Breast Cancer Res Treat. 2018 Jan;167(1):89-99. doi: 10.1007/s10549-017-4499-7. Epub 2017 Sep 14.

35.

MRI and Additive Manufacturing of Nasal Alar Constructs for Patient-specific Reconstruction.

Visscher DO, van Eijnatten M, Liberton NPTJ, Wolff J, Hofman MBM, Helder MN, Don Griot JPW, Zuijlen PPMV.

Sci Rep. 2017 Aug 30;7(1):10021. doi: 10.1038/s41598-017-10602-9.

36.

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.

Goetz MP, Suman VJ, Reid JM, Northfelt DW, Mahr MA, Ralya AT, Kuffel M, Buhrow SA, Safgren SL, McGovern RM, Black J, Dockter T, Haddad T, Erlichman C, Adjei AA, Visscher D, Chalmers ZR, Frampton G, Kipp BR, Liu MC, Hawse JR, Doroshow JH, Collins JM, Streicher H, Ames MM, Ingle JN.

J Clin Oncol. 2017 Oct 20;35(30):3391-3400. doi: 10.1200/JCO.2017.73.3246. Epub 2017 Aug 30.

37.

Tissue-based associations of mammographic breast density with breast stem cell markers.

Yaghjyan L, Stoll E, Ghosh K, Scott CG, Jensen MR, Brandt KR, Visscher D, Vachon CM.

Breast Cancer Res. 2017 Aug 29;19(1):100. doi: 10.1186/s13058-017-0889-3.

38.

NanoString-based breast cancer risk prediction for women with sclerosing adenosis.

Winham SJ, Mehner C, Heinzen EP, Broderick BT, Stallings-Mann M, Nassar A, Vierkant RA, Hoskin TL, Frank RD, Wang C, Denison LA, Vachon CM, Frost MH, Hartmann LC, Aubrey Thompson E, Sherman ME, Visscher DW, Degnim AC, Radisky DC.

Breast Cancer Res Treat. 2017 Nov;166(2):641-650. doi: 10.1007/s10549-017-4441-z. Epub 2017 Aug 10.

39.

Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.

Fang H, Langstraat CL, Visscher DW, Folpe AL, Schoolmeester JK.

Int J Gynecol Pathol. 2018 Sep;37(5):468-472. doi: 10.1097/PGP.0000000000000431.

PMID:
28787324
40.

Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution.

Stallings-Mann ML, Heinzen EP, Vierkant RA, Winham SJ, Hoskin TL, Denison LA, Nassar A, Hartmann LC, Visscher DW, Frost MH, Sherman ME, Degnim AC, Radisky DC.

Breast Cancer Res Treat. 2017 Nov;166(1):133-143. doi: 10.1007/s10549-017-4413-3. Epub 2017 Jul 27.

41.

Breast implant capsule-associated squamous cell carcinoma: a report of 2 cases.

Olsen DL, Keeney GL, Chen B, Visscher DW, Carter JM.

Hum Pathol. 2017 Sep;67:94-100. doi: 10.1016/j.humpath.2017.07.011. Epub 2017 Jul 22.

PMID:
28739500
42.

Nutritional state reveals complex consequences of risk in a wild predator-prey community.

DeWitt PD, Schuler MS, Visscher DR, Thiel RP.

Proc Biol Sci. 2017 Jul 12;284(1858). pii: 20170757. doi: 10.1098/rspb.2017.0757.

43.

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts.

Butler KA, Hou X, Becker MA, Zanfagnin V, Enderica-Gonzalez S, Visscher D, Kalli KR, Tienchaianada P, Haluska P, Weroha SJ.

Neoplasia. 2017 Aug;19(8):628-636. doi: 10.1016/j.neo.2017.04.007. Epub 2017 Jun 26.

44.

Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes.

Yaghjyan L, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Pankratz VS, Brandt K, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM.

Breast Cancer Res Treat. 2017 Sep;165(2):421-431. doi: 10.1007/s10549-017-4341-2. Epub 2017 Jun 17.

45.

Breast cysts rapidly enlarging with replacement of breast parenchyma and asymmetry.

Al-Hilli Z, Javed A, Boughey JC, Lemaine V, Visscher DW, Pruthi S.

Breast J. 2018 Jan;24(1):83-85. doi: 10.1111/tbj.12839. Epub 2017 Jun 7. No abstract available.

PMID:
28590556
46.

Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.

Peña A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, Jakub JW, Boughey JC, Visscher DW, Degnim AC.

Breast Cancer Res Treat. 2017 Jul;164(2):295-304. doi: 10.1007/s10549-017-4253-1. Epub 2017 May 4. Review.

PMID:
28474262
47.

Non-BRCA familial breast cancer: review of reported pathology and molecular findings.

Keeney MG, Couch FJ, Visscher DW, Lindor NM.

Pathology. 2017 Jun;49(4):363-370. doi: 10.1016/j.pathol.2017.03.002. Epub 2017 Apr 24. Review.

48.

Neuroendocrine Tumors of the Breast.

Visscher DW, Yasir S.

Endocr Pathol. 2017 Jun;28(2):121-127. doi: 10.1007/s12022-017-9477-4. Review.

PMID:
28389994
49.

Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.

Visscher DW, Frank RD, Carter JM, Vierkant RA, Winham SJ, Heinzen EP, Broderick BT, Denison LA, Allers TM, Johnson JL, Frost MH, Hartmann LC, Degnim AC, Radisky DC.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx035.

50.

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.

Goetz MP, Kalari KR, Suman VJ, Moyer AM, Yu J, Visscher DW, Dockter TJ, Vedell PT, Sinnwell JP, Tang X, Thompson KJ, McLaughlin SA, Moreno-Aspitia A, Copland JA, Northfelt DW, Gray RJ, Hunt K, Conners A, Sicotte H, Eckel-Passow JE, Kocher JP, Ingle JN, Ellingson MS, McDonough M, Wieben ED, Weinshilboum R, Wang L, Boughey JC.

J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djw306.

Supplemental Content

Loading ...
Support Center